Cargando…
Growth factor for therapeutic angiogenesis in ischemic heart disease: A meta-analysis of randomized controlled trials
Aim: This study was designed to systematically evaluate the effects of growth factor (GF) for therapeutic angiogenesis on ischemic heart disease (IHD) by pooling the results of randomized controlled trials (RCTs). Methods and Results: PubMed, EMBASE, and CENTRAL databases were searched from inceptio...
Autores principales: | Tan, Ling, Long, Lin-Zi, Li, Hong-Zheng, Yang, Wen-Wen, Peng, Yu-Xuan, Lu, Jie-Ming, Liao, Fei-Fei, Ma, Xiao-Chang, Qu, Hua, Fu, Chang-Geng, Zhang, Shan-Shan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780500/ https://www.ncbi.nlm.nih.gov/pubmed/36568984 http://dx.doi.org/10.3389/fcell.2022.1095623 |
Ejemplares similares
-
The role of the ERK signaling pathway in promoting angiogenesis for treating ischemic diseases
por: Song, Yue-Yue, et al.
Publicado: (2023) -
The Role of Syncytin in Placental Angiogenesis and Fetal Growth
por: Wang, Ya-Nan, et al.
Publicado: (2022) -
Transformed extracellular vesicles with high angiogenic ability as therapeutics of distal ischemic tissues
por: Ngo, Nhat-Hoang, et al.
Publicado: (2022) -
Tubulin Post-translational Modifications: Potential Therapeutic Approaches to Heart Failure
por: Liu, Chang, et al.
Publicado: (2022) -
PFKFB3: A Potential Key to Ocular Angiogenesis
por: Zhou, Zi-Yi, et al.
Publicado: (2021)